Health professionals will have the possibility to interact live with 5 of the most outstanding professionals in prenatal screening and address your questions directly to the experts. A Certificate of Attendance will be sent to all participants. During the course of the workshop, particpants will gain an understanding from real-life experience about clinical implementation of first trimester pre-eclampsia screening in different settings in different countries.
They will also:
- Get an insight on different parameters needed for efficient pre-eclampsia screening including ultrasound, serum biomarkers as well as health economic aspects
- Directly discuss your most urgent questions on pre-eclampsia screening with international experts
REGISTER FOR THE EVENT AT THIS ADDRESS.
- Welcome from Chairman
Kevin Spencer, UK
- Ultrasound aspects and implementation in Hong Kong
Liona Poon, Hong Kong
- Lab perspective and implementation in Toulouse
Safouane Hamdi, France
- Health economic aspects and implementation in Dresden
Cahit Birdir, Germany
- Implementation and effectiveness of early PE screening in London
Basky Thilaganathan, UK
- Former Consultant Biochemist & Clinical Lead
- Kings George Hospital, London, UK
- Prof. Kevin Spencer is a former Consultant Biochemist and Clinical Lead in Biochemistry at BHRUT and is now retired. He also is a Visiting Professor in Reproductive Biochemistry at King’s College, London and Director of Biochemical Screening at the Fetal Medicine Foundation (London). Prof. Spencer has a Hirsch Publications Index of 51 as of 2012.
- Professor (Clinical)
- Prince of Wales Hospital, Hong Kong
- Liona Poon was awarded MBBS from University of London in 2002 and undertook her specialty training in Obstetrics and Gynaecology in London. She gained a 3-year training fellowship from the Fetal Medicine Foundation and during this time, established a major screening programme for early detection of preeclampsia, which led to a Doctorate of Medicine (Research) in 2011. She then undertook subspecialty training in maternal fetal medicine at Imperial College Healthcare NHS Trust and King’s College Hospital NHS Foundation Trust with Mr TG Teoh and Professor KH Nicolaides as supervisors.
- Assistant-Professor of Hormonology and Senior Researcher at the Research Group on Human Fertility
- Toulouse University, France
- Safouane Hamdi (Pharm D, PhD) is an Assistant-Professor of Reproductive Hormonology and Senior Researcher at the French Institute of Medical Research (INSERM). He is also a Hospital Practioner at the Central Laboratory of the University Hospital of Toulouse. His area of expertise encompasses the development and the use of biomarkers in human infertility and pregnancy-related diseases.
- Head of Obstetrics and Prenatal Medicine
- Universitätsfrauenklinik Dresden, Germany
- Prof. Birdir holds a graduation in medicine from the University of Yeditepe, Istanbul and is a Specialist of Obstetrics and Gynaecology by Ärztekammer Nordrhein, Germany. He was a research Fellow at Harris Birthright Research Centre, King’s College Hospital, London and holds a diploma for fetal medicine from Fetal Medicine Foundation, London. Prof. Birdir is certified as DEGUM Level II.
- Professor in Fetal Medicine and Consultant Obstetrician and Director, Fetal Medicine Unit St Georges St George’s Hospital, London, UK
- Basky Thilaganathan was appointed Director of Fetal Medicine at St George’s Hospital in 1999. He was awarded the Fellowship of the Royal College of Obstetricians and Gynaecologists (FRCOG) and an Honorary Doctorate (PhD) from Uppsala University in 2007.He is the Clinical Director of the Tommy’s National Centre for Maternity Improvement located at the RCOG/RCM and is Editor Emeritus of Ultrasound in Obstetrics and Gynaecology. He is a Council Member on the Royal College of Obstetrics and Gynaecology (RCOG) and represents the RCOG on the UK National Screening Committee.
- He has authored over 300 peer-reviewed publications in indexed journals. His major research interest is placental dysfunction leading to pre-eclampsia, fetal growth restriction and stillbirth. He has led on the implementation of algorithm-based screening at St Georges which has led to an 80% reduction in preterm pre-eclampsia .